Use access key #2 to skip to page content.
$17.95 0.06 (0.34%)
12/5/2008 12:13 PM

Alnylam Pharmaceuticals, Inc. (ALNY)

CAPS Rating:
***

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

View All Commentary (ALNY)

Recs

0

Avatar chickenghost (< 20) Submitted: 7/12/08 3:29 PM : Outperform Start Price: $29.00 ALNY Score: -5.31

RNAi

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links